TrialClinical pharmacology in drug development2026

Bioequivalence of a Fixed-Dose Combination of Relugolix, Estradiol, and Norethindrone Acetate: An Open-Label, Randomized, Fully Replicate Crossover Study in Healthy Postmenopausal Women Under Fasting Conditions.

Ravi Kotadia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.